173 related articles for article (PubMed ID: 27507009)
21. Efficient transgene insertion in a pseudorabies virus vector by CRISPR/Cas9 and marker rescue-enforced recombination.
Hübner A; Keil GM; Kabuuka T; Mettenleiter TC; Fuchs W
J Virol Methods; 2018 Dec; 262():38-47. PubMed ID: 30248362
[TBL] [Abstract][Full Text] [Related]
22. Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms.
Dong Z; Qin Q; Hu Z; Chen P; Huang L; Zhang X; Tian T; Lu C; Pan M
Virol Sin; 2019 Aug; 34(4):444-453. PubMed ID: 31218589
[TBL] [Abstract][Full Text] [Related]
23. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
[TBL] [Abstract][Full Text] [Related]
24. CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape.
Wang Z; Pan Q; Gendron P; Zhu W; Guo F; Cen S; Wainberg MA; Liang C
Cell Rep; 2016 Apr; 15(3):481-489. PubMed ID: 27068471
[TBL] [Abstract][Full Text] [Related]
25. Generation and characterization of UL41 null pseudorabies virus variant in vitro and in vivo.
Ye C; Chen J; Wang T; Xu J; Zheng H; Wu J; Li G; Yu Z; Tong W; Cheng X; Zhou S; Tong G
Virol J; 2018 Aug; 15(1):119. PubMed ID: 30071879
[TBL] [Abstract][Full Text] [Related]
26. Pseudorabies Virus Infection Triggers NF-κB Activation via the DNA Damage Response but Actively Inhibits NF-κB-Dependent Gene Expression.
Romero N; Favoreel HW
J Virol; 2021 Nov; 95(24):e0166621. PubMed ID: 34613805
[TBL] [Abstract][Full Text] [Related]
27. RNA silencing suppressor-influenced performance of a virus vector delivering both guide RNA and Cas9 for CRISPR gene editing.
Chiong KT; Cody WB; Scholthof HB
Sci Rep; 2021 Mar; 11(1):6769. PubMed ID: 33762584
[TBL] [Abstract][Full Text] [Related]
28. Targeting the pseudorabies virus DNA polymerase processivity factor UL42 by RNA interference efficiently inhibits viral replication.
Wang YP; Huang LP; Du WJ; Wei YW; Wu HL; Feng L; Liu CM
Antiviral Res; 2016 Aug; 132():219-24. PubMed ID: 27387827
[TBL] [Abstract][Full Text] [Related]
29. The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape.
Darcis G; Binda CS; Klaver B; Herrera-Carrillo E; Berkhout B; Das AT
Viruses; 2019 Mar; 11(3):. PubMed ID: 30871200
[TBL] [Abstract][Full Text] [Related]
30. Efficient influence of ssDNA virus PCV2 replication by CRISPR/Cas9 targeting of the viral genome.
Shi J; Zheng S; Wu X; Peng Z; Li C; Wang S; Xin C; Xu S; Li J
Mol Immunol; 2021 May; 133():63-66. PubMed ID: 33631556
[TBL] [Abstract][Full Text] [Related]
31. Targeting human cytomegalovirus IE genes by CRISPR/Cas9 nuclease effectively inhibits viral replication and reactivation.
Xiao J; Deng J; Zhang Q; Ma P; Lv L; Zhang Y; Li C; Zhang Y
Arch Virol; 2020 Aug; 165(8):1827-1835. PubMed ID: 32507978
[TBL] [Abstract][Full Text] [Related]
32. Phospho-proteomics identifies a critical role of ATF2 in pseudorabies virus replication.
Jiang FF; Wang RQ; Guo CY; Zheng K; Liu HL; Su L; Xie SS; Chen HC; Liu ZF
Virol Sin; 2022 Aug; 37(4):591-600. PubMed ID: 35688418
[TBL] [Abstract][Full Text] [Related]
33. CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus.
Ramanan V; Shlomai A; Cox DB; Schwartz RE; Michailidis E; Bhatta A; Scott DA; Zhang F; Rice CM; Bhatia SN
Sci Rep; 2015 Jun; 5():10833. PubMed ID: 26035283
[TBL] [Abstract][Full Text] [Related]
34. Generation of pRSAD2 gene knock-in pig via CRISPR/Cas9 technology.
Xie Z; Jiao H; Xiao H; Jiang Y; Liu Z; Qi C; Zhao D; Jiao S; Yu T; Tang X; Pang D; Ouyang H
Antiviral Res; 2020 Feb; 174():104696. PubMed ID: 31862502
[TBL] [Abstract][Full Text] [Related]
35. Construction of a US7/US8/UL23/US3-deleted recombinant pseudorabies virus and evaluation of its pathogenicity in dogs.
Yin H; Li Z; Zhang J; Huang J; Kang H; Tian J; Qu L
Vet Microbiol; 2020 Jan; 240():108543. PubMed ID: 31902487
[TBL] [Abstract][Full Text] [Related]
36. Resistance to pseudorabies virus by knockout of nectin1/2 in pig cells.
Huang Y; Li Z; Song C; Wu Z; Yang H
Arch Virol; 2020 Dec; 165(12):2837-2846. PubMed ID: 33025197
[TBL] [Abstract][Full Text] [Related]
37. Combinatorial CRISPR-Cas9 and RNA Interference Attack on HIV-1 DNA and RNA Can Lead to Cross-Resistance.
Zhao N; Wang G; Das AT; Berkhout B
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893790
[TBL] [Abstract][Full Text] [Related]
38. Functional analysis of prv-miR-LLT11a encoded by pseudorabies virus.
Liu H; Yang L; Shi Z; Lv R; Yang X; Wang C; Chen L; Chang H
J Vet Sci; 2019 Nov; 20(6):e68. PubMed ID: 31775195
[TBL] [Abstract][Full Text] [Related]
39. Construction of Baculovirus-Inducible CRISPR/Cas9 Antiviral System Targeting BmNPV in
Liu Y; Chen D; Zhang X; Chen S; Yang D; Tang L; Yang X; Wang Y; Luo X; Wang M; Hu Z; Huang Y
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062262
[TBL] [Abstract][Full Text] [Related]
40. A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.
Lebbink RJ; de Jong DC; Wolters F; Kruse EM; van Ham PM; Wiertz EJ; Nijhuis M
Sci Rep; 2017 Feb; 7():41968. PubMed ID: 28176813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]